Works by Park, Keunchil


Results: 205
    1

    An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.

    Published in:
    2021
    By:
    • Keunchil Park;
    • Jin-Soo Kim;
    • Joo-Hang Kim;
    • Young-Chul Kim;
    • Hoon-Gu Kim;
    • Eun Kyung Cho;
    • Jong-Youl Jin;
    • Miyoung Kim;
    • Märten, Angela;
    • Jin-Hyoung Kang;
    • Park, Keunchil;
    • Kim, Jin-Soo;
    • Kim, Joo-Hang;
    • Kim, Young-Chul;
    • Kim, Hoon-Gu;
    • Cho, Eun Kyung;
    • Jin, Jong-Youl;
    • Kim, Miyoung;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4

    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
    By:
    • Schuler, Martin;
    • Tan, Eng-Huat;
    • O'Byrne, Kenneth;
    • Zhang, Li;
    • Boyer, Michael;
    • Mok, Tony;
    • Hirsh, Vera;
    • Yang, James Chih-Hsin;
    • Lee, Ki Hyeong;
    • Lu, Shun;
    • Shi, Yuankai;
    • Kim, Sang-We;
    • Laskin, Janessa;
    • Kim, Dong-Wan;
    • Arvis, Catherine Dubos;
    • Kölbeck, Karl;
    • Massey, Dan;
    • Märten, Angela;
    • Paz-Ares, Luis;
    • Park, Keunchil
    Publication type:
    Article
    5
    6
    7
    8

    Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 6, p. 2083, doi. 10.1245/s10434-014-3540-x
    By:
    • Lee, Hyebin;
    • Ahn, Yong;
    • Pyo, Hongryull;
    • Kim, BoKyong;
    • Oh, Dongryul;
    • Nam, Heerim;
    • Lee, Eunju;
    • Sun, Jong-Mu;
    • Ahn, Jin;
    • Ahn, Myung-Ju;
    • Park, Keunchil;
    • Choi, Yong;
    • Kim, Jhingook;
    • Zo, Jae;
    • Shim, Young
    Publication type:
    Article
    9
    10

    Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e239, doi. 10.1111/ajco.12645
    By:
    • Lim, Sung Hee;
    • Yoh, Kyung Ah;
    • Lee, Jong Seok;
    • Ahn, Myung‐ju;
    • Kim, Yu Jung;
    • Kim, Se Hyun;
    • Zhang, Jie;
    • Patel, Dony;
    • Swallow, Elyse;
    • Kageleiry, Andrew;
    • Galebach, Philip;
    • Lee, Dongyeol;
    • Stein, Karen;
    • Degun, Ravi;
    • Park, Keunchil
    Publication type:
    Article
    11
    12

    L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60.

    Published in:
    Journal of Cellular Biochemistry, 2004, v. 93, n. 2, p. 257, doi. 10.1002/jcb.20116
    By:
    • Seong‐Su Han;
    • Kihyun Kim;
    • Eun‐Ryeong Hahm;
    • Sook J. Lee;
    • Young‐Joon Surh;
    • Hye K. Park;
    • Won S. Kim;
    • Chul W. Jung;
    • Mark H. Lee;
    • Keunchil Park;
    • Jung‐Hyun Yang;
    • Sung‐Soo Yoon;
    • Neil H. Riordan;
    • Hugh D. Riordan;
    • Bruce F. Kimler;
    • Chan H. Park;
    • Je‐Ho Lee;
    • Seyeon Park
    Publication type:
    Article
    13
    14
    15
    16
    17

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    18

    Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

    Published in:
    Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
    By:
    • Shin, Junghoon;
    • Park, Sehhoon;
    • Kim, Kyung Hwan;
    • Shin, Eui-Cheol;
    • Jung, Hyun Ae;
    • Cho, Jong Ho;
    • Sun, Jong-Mu;
    • Lee, Se-Hoon;
    • Choi, Yong Soo;
    • Ahn, Jin Seok;
    • Kim, Jhingook;
    • Park, Keunchil;
    • Shim, Young Mog;
    • Kim, Hong Kwan;
    • Noh, Jae Myoung;
    • Ahn, Yong Chan;
    • Pyo, Hongryull;
    • Ahn, Myung-Ju
    Publication type:
    Article
    19
    20
    21

    Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
    By:
    • Byoung Chul Cho;
    • Dong-Wan Kim;
    • Ullas Batra;
    • Keunchil Park;
    • Sang-We Kim;
    • Cheng-Ta Yang;
    • Pei-Jye Voon;
    • Virote Sriuranpong;
    • K. Govind Babu;
    • Khalid Amin;
    • Yingbo Wang;
    • Paramita Sen;
    • Khemaies Slimane;
    • Sarayut Geater
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
    By:
    • Dong-Wan Kim;
    • Hoon-Gu Kim;
    • Joo-Hang Kim;
    • Keunchil Park;
    • Hoon-Kyo Kim;
    • Joung Soon Jang;
    • Bong-Seog Kim;
    • Jin-Hyoung Kang;
    • Kyung Hee Lee;
    • Sang-We Kim;
    • Hun Mo Ryoo;
    • Jin-Soo Kim;
    • Ki Hyeong Lee;
    • Jung Hye Kwon;
    • Jin-Hyuk Choi;
    • Sang Won Shin;
    • Seokyung Hahn;
    • Dae Seog Heo
    Publication type:
    Article
    29
    30
    31

    Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
    By:
    • Keunchil Park;
    • Eun Kyung Cho;
    • Maximino Bello;
    • Myung-Ju Ahn;
    • Thongprasert, Sumitra;
    • Eun-Kee Song;
    • Soldatenkova, Victoria;
    • Depenbrock, Henrik;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    32
    33

    East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401
    By:
    • Keunchil Park;
    • Joo-Hang Kim;
    • Eun Kyung Cho;
    • Jin-Hyoung Kang;
    • Jin-Yuan Shih;
    • Zimmermann, Annamaria Hayden;
    • Pablo Lee;
    • Alexandris, Ekaterine;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    34
    35

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    36
    37

    Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy.

    Published in:
    Cancer Research & Treatment, 2015, v. 47, n. 4, p. 871, doi. 10.4143/crt.2014.141
    By:
    • Min Kyu Kang;
    • Dongryul Oh;
    • Kwan Ho Cho;
    • Sung Ho Moon;
    • Hong-Gyun Wu;
    • Dae-Seog Heo;
    • Yong Chan Ahn;
    • Keunchil Park;
    • Hyo Jung Park;
    • Jun Su Park;
    • Ki Chang Keum;
    • Jihye Cha;
    • Jun Won Kim;
    • Yeon-Sil Kim;
    • Jin Hyoung Kang;
    • Young-Taek Oh;
    • Ji-Yoon Kim;
    • Sung Hwan Kim;
    • Jin-Hee Kim;
    • Chang Geol Lee
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695
    By:
    • Sequist, Lecia V.;
    • Gray, Jhanelle Elaine;
    • Harb, Wael A.;
    • Lopez‐Chavez, Ariel;
    • Doebele, Robert C.;
    • Modiano, Manuel R.;
    • Jackman, David Michael;
    • Baggstrom, Maria Quintos;
    • Atmaca, Akin;
    • Felip, Enriqueta;
    • Provencio, Mariano;
    • Cobo, Manuel;
    • Adiwijaya, Bambang;
    • Kuesters, Geoffrey;
    • Kamoun, Walid S.;
    • Andreas, Karen;
    • Pipas, J. Marc;
    • Santillana, Sergio;
    • Cho, Byoung Chul;
    • Park, Keunchil
    Publication type:
    Article